Hanson JEL - Search Results

1

Induction of senescence in primary glioblastoma cells by serum and TGFβ.

Kumar R, Gont A, Perkins TJ, Hanson JEL, Lorimer IAJ. Kumar R, et al. Among authors: hanson jel. Sci Rep. 2017 May 19;7(1):2156. doi: 10.1038/s41598-017-02380-1. Sci Rep. 2017. PMID: 28526854 Free PMC article.

2

Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.

Mantha AJ, Hanson JE, Goss G, Lagarde AE, Lorimer IA, Dimitroulakos J. Mantha AJ, et al. Clin Cancer Res. 2005 Mar 15;11(6):2398-407. doi: 10.1158/1078-0432.CCR-04-1951. Clin Cancer Res. 2005. PMID: 15788691

3

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

Vickers MM, Bar J, Gorn-Hondermann I, Yarom N, Daneshmand M, Hanson JE, Addison CL, Asmis TR, Jonker DJ, Maroun J, Lorimer IA, Goss GD, Dimitroulakos J. Vickers MM, et al. Clin Exp Metastasis. 2012 Feb;29(2):123-32. doi: 10.1007/s10585-011-9435-3. Epub 2011 Nov 26. Clin Exp Metastasis. 2012. PMID: 22120473

4

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases.

Daneshmand M, Hanson JE, Nabavi M, Hilton JF, Vandermeer L, Kanji F, Dent SF, Clemons M, Lorimer IA. Daneshmand M, et al. ISRN Oncol. 2012;2012:492578. doi: 10.5402/2012/492578. Epub 2012 Aug 30. ISRN Oncol. 2012. PMID: 22970388 Free PMC article.

5

PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.

Gont A, Hanson JE, Lavictoire SJ, Parolin DA, Daneshmand M, Restall IJ, Soucie M, Nicholas G, Woulfe J, Kassam A, Da Silva VF, Lorimer IA. Gont A, et al. Oncotarget. 2013 Aug;4(8):1266-79. doi: 10.18632/oncotarget.1164. Oncotarget. 2013. PMID: 23907540 Free PMC article.

6

Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma multiforme through de-repression of Bcl-xL translation.

Liwak U, Jordan LE, Von-Holt SD, Singh P, Hanson JE, Lorimer IA, Roncaroli F, Holcik M. Liwak U, et al. Oncotarget. 2013 Sep;4(9):1365-72. doi: 10.18632/oncotarget.1154. Oncotarget. 2013. PMID: 23965755 Free PMC article.

7

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Karapetis CS, Jonker D, Daneshmand M, Hanson JE, O'Callaghan CJ, Marginean C, Zalcberg JR, Simes J, Moore MJ, Tebbutt NC, Price TJ, Shapiro JD, Pavlakis N, Gibbs P, Van Hazel GA, Lee U, Haq R, Virk S, Tu D, Lorimer IA; NCIC Clinical Trials Group and the Australasian Gastro-Intestinal Trials Group. Karapetis CS, et al. Clin Cancer Res. 2014 Feb 1;20(3):744-53. doi: 10.1158/1078-0432.CCR-13-0606. Epub 2013 Nov 11. Clin Cancer Res. 2014. PMID: 24218517 Clinical Trial.

8

Inhibition of glioblastoma malignancy by Lgl1.

Gont A, Hanson JE, Lavictoire SJ, Daneshmand M, Nicholas G, Woulfe J, Kassam A, Da Silva VF, Lorimer IA. Gont A, et al. Oncotarget. 2014 Nov 30;5(22):11541-51. doi: 10.18632/oncotarget.2580. Oncotarget. 2014. PMID: 25426552 Free PMC article.

9

PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma.

Restall IJ, Parolin DA, Daneshmand M, Hanson JE, Simard MA, Fitzpatrick ME, Kumar R, Lavictoire SJ, Lorimer IA. Restall IJ, et al. Cell Cycle. 2015;14(18):2938-48. doi: 10.1080/15384101.2015.1071744. Cell Cycle. 2015. PMID: 26208522 Free PMC article.

10

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers.

Schlosser K, Hanson J, Villeneuve PJ, Dimitroulakos J, McIntyre L, Pilote L, Stewart DJ. Schlosser K, et al. Sci Rep. 2016 Nov 18;6:36596. doi: 10.1038/srep36596. Sci Rep. 2016. PMID: 27857151 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page